This guideline is designed primarily as an educational resource for medical geneticists and other health care providers to help them provide quality medical genetic services. Adherence to this guideline does not necessarily assure a successful medical outcome. This guideline should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed to obtaining the same results. In determining the propriety of any specific procedure or test, the geneticist should apply his or her own professional judgment to the specific clinical circumstances presented by the individual patient or specimen. It may be prudent, however, to document in the patient's record the rationale for any significant deviation from this guideline.

OVERVIEW
========

Osteogenesis imperfecta (OI) is an inherited disorder of connective tissue characterized by bone fragility and fractures; other clinical features include blue sclerae, adult onset hearing loss and joint laxity.[@b1-16778601] The severity ranges from lethal in the perinatal period to occasional fracture. Inheritance is generally autosomal dominant but new mutations are common and recessive inheritance occurs. In most instances (about 90%), a mutation in one of the two genes (*COL1A1* and *COL1A2*) that encode the chains of type I collagen, the major protein of bone, accounts for the phenotype.[@b2-16778601] Less frequently, yet-to-be-identified genes are responsible.[@b3-16778601]--[@b5-16778601] The diagnosis of OI is considered at different times: during fetal development, at birth, in childhood, or less often in adults. Regardless of the time at which the diagnosis is suspected, the first line of evaluation is a detailed medical history, family history, physical examination, appropriate radiographs and routine lab testing. If these do not lead to diagnosis, then specialized genetic testing is warranted. We have organized the approach to diagnosis of OI in an age-specific fashion.

OI: IDENTIFICATION IN PREGNANCY
===============================

OI may be suspected in a fetus at different gestational ages, depending on whether the clinical question is raised by family history or by routine ultrasound examination.

In the presence of a positive family history of OI
--------------------------------------------------

The fetus is usually at a 50% risk for OI when a parent has OI. When only a sibling has OI, the risk varies from 0% to 50%, reflecting the proportion of parental gametes that have the mutation in a mosaic pattern.[@b6-16778601] Both targeted ultrasound examinations and laboratory testing (protein-based or DNA-based) can be considered.

*Fetal Ultrasound Examination*: Ultrasound examination, trans-abdominal (TA) or trans-vaginal (TV)[@b7-16778601],[@b8-16778601] should be offered as early as 13--14 weeks gestation for a pregnancy at risk for the severe, lethal form of OI (OI type II) and 16--20 weeks for one at risk for OI type III. Ultrasound identification of OI type I and OI type IV has been reported infrequently after 20 weeks gestation on the basis of fetal fracture, but cannot be relied upon.[@b8-16778601] ([Table 1](#t1-16778601){ref-type="table"}, [Fig. 1](#f1-16778601){ref-type="fig"})

### Laboratory Testing

For the pregnancy at risk for most forms of OI (OI type II, III or IV) on the basis of family history, biochemical analysis of type I collagen synthesized by cultured chorionic villi cells (CVS) can be offered *if* collagen screening studies have been completed on the affected parent or a previous affected infant and shown to be abnormal.[@b6-16778601] The time from CVS biopsy to final diagnosis is about 3--4 weeks. *The same biochemical assay cannot be performed on amniocytes as they synthesize inadequate amounts of type I procollagen*. Prenatal diagnosis by *biochemical* testing is not available for the identification of OI type I. The reduced synthesis of type I collagen chains typically seen in cells from individuals with OI type I cannot be detected reliably in CVS cells.

Mutation analysis can be performed for all types of OI, if the mutation in the family is known, using DNA extracted from CVS cells or amniocytes. The time from initial tissue sampling to test result is about 7--14 days.

In routine care of the pregnant woman with a negative family history of OI
--------------------------------------------------------------------------

Ultrasound detection of skeletal anomalies may raise the suspicion of OI. When micromelia and undermineralization of the skeleton are found at 14--16 weeks gestation, the major differential includes OI type II, achondrogenesis types IA, IB and II, and autosomal recessive (severe infantile) hypophosphatasia ([Table 2](#t2-16778601){ref-type="table"}). In experienced centers, the sonographic evaluation will generally lead to a specific diagnosis. For most disorders, the gene(s) in which causative mutations lie are known but, because most mutations are unique to a family or individual, their identification may take several weeks. As a result, a discussion about pregnancy continuation or termination generally rests on sonographic evaluation ([Table 2](#t2-16778601){ref-type="table"}).

When termination is performed on the basis of ultrasound findings, the specific diagnosis, including OI, can be determined by biochemical study of cultured cells or analysis of DNA from the fetus. Detailed postmortem evaluation and x-rays of the fetus are a necessary adjunct to diagnosis. If the pregnancy is continued to delivery, the genetic evaluation can be completed in the newborn period.

OI type III is seldom identified before 18 weeks gestation and confirmation of the diagnosis often requires serial ultrasounds to track evolving findings. The prenatal phenotype overlaps that of perinatal hypophosphatasia (frequency of 1/100,000) ([Table 3](#t3-16778601){ref-type="table"}).

OI: IDENTIFICATION IN CHILDHOOD
===============================

In infancy and childhood, the clinical examination is the key first step in evaluation of the child with suspected OI. The evaluation requires familiarity with the natural history and variation in clinical presentation of OI, particularly in the infant or toddler. Mild forms of OI may go unnoticed by even experienced general clinicians. Referral to an experienced physician familiar with the range of clinical expression of OI (such as a medical geneticist) is relatively inexpensive in comparison to laboratory testing and may be all that is necessary to secure the diagnosis. There are several clinical circumstances that lead to the evaluation of a child for a brittle bone disorder such as OI.

Family history of OI
--------------------

When a parent or relative is affected, the physical examination and radiographic findings in the child may be sufficient for *clinical* confirmation of OI. Exclusion of the diagnosis may be more difficult in individuals with mild forms. If the infant or toddler has few or equivocal findings, the clinician may adopt a wait and watch approach. If the family wishes to pursue prenatal diagnosis in a subsequent pregnancy, then laboratory testing (biochemical or DNA-based testing) is necessary.

Frequent fractures
------------------

At birth, OI types II and III are generally recognized on clinical and radiologic grounds and the clinical diagnosis is usually unequivocal.[@b1-16778601] Genetic evaluation and counseling is recommended for confirmation and discussion about natural history, treatment and prenatal diagnosis in future pregnancies.

In childhood, in the absence of a positive family history, most children newly diagnosed with OI are identified after one or more fractures. The severity of the phenotype varies from the progressive deforming type (OI type III) to the mild phenotype of OI type I (see [Table 3](#t3-16778601){ref-type="table"}). The differential diagnosis for frequent fracture in childhood is relatively limited and includes both inherited and acquired conditions. Hypophosphatasia, osteopetrosis with renal tubular acidosis, hypophosphatemic osteomalacia (rickets) and nonaccidental injury should be considered.

Short stature, blue sclerae and dentinogenesis imperfecta (DI)
--------------------------------------------------------------

Sometimes, the evaluation for OI in childhood is prompted by recognition of blue sclerae, conductive hearing loss, dentinogenesis imperfecta (DI) or during an evaluation for short stature. Blue sclerae are present in all children with OI type I and are, at times, dramatic. Roughly 20% of families with OI type I have DI. Infants and toddlers with OI type IV may have light blue sclerae and usually have DI, which may be subtle. Some children may be identified by short stature as about a third of individuals with OI type IV are less than the third percent for height in childhood ([Table 4](#t4-16778601){ref-type="table"}).[@b9-16778601]

The infant or toddler with "unexplained fractures"
--------------------------------------------------

In the first year of life, the presence of fractures for which an explanation is not provided or for which the stated mechanism of injury is not consistent with the fracture type raises a concern for nonaccidental injury (NAI). As NAI is the leading cause of fractures in infancy, a child abuse evaluation is warranted in such circumstances (<http://nccanch.acf.hhs.gov/>). If a biological basis for brittle bones is suspected and clinical examination is not definitive, then laboratory testing for OI and select metabolic bone disorders is generally appropriate.

On clinical examination, if an infant with unexplained fractures has few features of OI, as may be the case with OI type I, IV, V and VI, it may be difficult to confirm or exclude the diagnosis on the basis of family history, history and physical examination alone, particularly in the 0--8 months age group.

Some clinical features of OI overlap with normal findings in infancy. For example: blue sclerae occur in normal infants before 12 months of age. However, with appropriate clinical evaluation, the diagnoses of OI type I and III are rarely in question. Infants with OI type IV, V and VI, with normal sclerae and normal length, may present only with fracture. Infants with OI can be missed on clinical evaluation and declared victims of NAI based on radiographic findings alone.[@b10-16778601],[@b11-16778601] Biochemical or DNA diagnostic testing, though not 100% sensitive, may be the best way to attempt to guard against these rare outcomes.[@b10-16778601],[@b11-16778601] When the index of clinical suspicion of OI is high, the physician may feel compelled to request testing to provide laboratory confirmation of the diagnosis in order to curtail additional Child Protective Services referrals.

The first studies[@b10-16778601] evaluating the usefulness and sensitivity of collagen screening for identification of OI in children with unexplained fractures suggested that the physical examination by a clinician familiar with OI was as sensitive as biochemical diagnostic testing for identifying the child with OI. A recent review of biochemical testing completed on cells from 262 infants with OI versus infants with unexplained fractures described 3 children who were not identified as affected by comprehensive clinical evaluation in whom a type I collagen abnormality was detected on biochemical testing. The collagen abnormality identified in each instance was characteristic for OI -- two with OI type I and one with OI type IV The clinical findings of the three infants in whom the clinical diagnosis of OI was not made could not be distinguished clinically from those who were positively identified by clinical examination. The expertise of the clinician and absence of any clinical findings were not contributing factors.[@b11-16778601] Thus, in instances when the clinical diagnosis of OI is not apparent and the only feature of NAI present is unexplained fractures, lab testing may be the best way to provide the child and family with all possible safeguards.

LABORATORY TESTING FOR OI
=========================

Laboratory diagnosis of OI depends on the determination that cultured fibroblasts make either less type I procollagen than normal, make abnormal type I procollagen molecules or the identification of a mutation in *COL1A1* or *COL1A2*, the two genes that encode the chains of type I procollagen. Collagen screening and DNA-based testing are available at the University of Washington ([www.pathology.washington.edu/clinical/collagen](www.pathology.washington.edu/clinical/collagen)) and DNA-based testing is available at the Tulane University Matrix DNA Diagnostic Lab (<http://www.som.tulane.edu/gene_therapy/matrix/matrix_dna_diagnostics.shtml>). Test sensitivity is high for both types of tests but it is not clear if the sensitivity is additive.[@b12-16778601],[@b13-16778601] Mutations in *COL1A1* and *COL1A2* do *not* cause OI type V, VI or VII, which account for about 8% of all children with OI.
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###### 

Ultrasound identification of OI during pregnancy (Listed in order of first ultrasound detection)

  Type                     Genetics              Clinical findings                                                                                                                             Ultrasound findings                                                                                                                                                       First ultrasound detection
  ------------------------ --------------------- --------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------
  OI II lethal perinatal   Autosomal dominant    Lethal perinatal type: Undermineralized skull, micromelic bones, "beaded" ribs on x-ray, bone deformity, platyspondyly                        Undermineralization, broad, crumpled and shortened limbs, thin beaded ribs, fractures, angulation or bowing of long bones, normal appearing hands, deformable calvarium   ≥14 wks
  OI III                   Autosomal dominant    Progressively deforming type: Moderate deformity of limbs at birth, sclerael hue varies, very short stature, dentinogenesis imperfecta (DI)   Thin ribs, short limbs, fractures, undermineralized skull, long bone length falls away from normal 16--18 weeks                                                           ≥18 wks
  OI IV                    Autosomal dominant    Normal sclerae, mild/moderate limb deformity with fracture, variable short stature, DI, some hearing loss                                     Rarely, long bone bowing and/or fracture                                                                                                                                  After 20 wks but not common
  OI I                     Autosomal dominant    Fractures with little or no limb deformity, blue sclerae, normal stature, hearing loss, DI                                                    Rarely, long bone bowing or fracture                                                                                                                                      \>20 wks but not common
  OI V                     Autosomal dominant    Similar to OI IV plus calcification of interosseous membrane of forearm, radial head dislocation, hyperplastic callus formation               Unknown                                                                                                                                                                   Not described
  OI VI                    Unknown               More fractures than OI type IV, vertebral compression fractures, no DI                                                                        Unknown                                                                                                                                                                   Not described
  OI VII                   Autosomal recessive   Congenital fractures, blue sclerae, early deformity of legs, coxa vara, osteopenia                                                            Unknown                                                                                                                                                                   Not described

###### 

Ultrasound differential diagnosis at 16 --18 weeks gestation

  Differential diagnosis                             Earliest ultrasound identification   Genetics   Characteristics                                                                                                                                      Possible lab testing
  -------------------------------------------------- ------------------------------------ ---------- ---------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------
  OI type II lethal type 1/60,000                    14--16 wks                           AD         Beaded ribs, micromelic limbs, fractures, undermineralized skull                                                                                     COL1A1/COL1A2 mutation identification
  Achondrogenesis type IB                            16 wks                               AR         Short limbs, short ribs, barrel shaped thorax & irregular scapulae, undermineralized sacral bones & skull, short undermineralized vertebral bodies   Diastrophic dysplasia sulfate transporter (DTDST) gene mutation identification[@b14-16778601]
  Achondrogenesis type IA                            14--16 wks                           AR         Short limbs, short ribs, splayed ends, rib fractures, undermineralized bones and skull, bowing, absent ossification of vertebral bodies & sacrum     Unknown
  Achondrogenes is type II                           14--16 wks                           AD         Extreme micromelia, barrel shaped thorax, undermineralized skull, bowing, absent ossification vertebral bodies & sacrum                              COL2A1 mutation identification[@b15-16778601]
  Perinatal/infantile Hypophosphatasia (1/100,000)   14--16 wks                           AR         Profound undermineralization of skeleton, underossification of skull and extremities, deformed limbs                                                 TNSALP mutations[@b16-16778601]
  Thamatrophoric sydplasia (1/30,000)                16 wks                               AD         Very short limgs, "telephone receiver femurs." Normal mineralzation, small chest                                                                     FGFR3 mutations[@b17-16778601]

###### 

Ultrasound differential diagnosis at 18--20 weeks gestation

  Differential diagnosis         Gestational weeks   Genetics   Characteristics                                                                                        Possible lab testing
  ------------------------------ ------------------- ---------- ------------------------------------------------------------------------------------------------------ ----------------------
  OI type III                    18--20 wks          AD         Shortened limbs, thin ribs, fractures/angulation/bowing                                                COL1A1/COL1A2
  Perinatal/infantile            \<20 wks            AR         Profound undermineralization of skeleton, underossification of skull and extremities, deformed limbs   TNSALP mutations
  Hypophosphatasia (1/100,000)                                                                                                                                         

###### 

Clinical presentation and Genetic differential diagnosis of fractures in childhood

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Type                                                         Inheritance   Clinical phenotype                                                                                                                                  Test
  ------------------------------------------------------------ ------------- --------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------
  OI type II                                                   AD            Lethal perinatal, undermineralized skull, beaded ribs, compressed femurs, long bone deformity, platyspondyly                                        Biochemical or Molecular

  OI type III                                                  AD/AR         Progressively deforming bones, moderate deformity at birth, sclerae hue varies, very short stature, DI                                              Biochemical or Molecular

  OI type I                                                    AD            Fracture with little or no deformity, blue sclerae, normal stature, hearing loss                                                                    Biochemical or Molecular

  OI type IV                                                   AD            Normal scleare, mild/moderate bone deformity with fracture, variable short stature, DI, some hearing loss                                           Biochemical or Molecular

  OI type V                                                    AD            Similar to OI IV plus calcification of interosseous membrane of forearm, radial head dislocation, hyperplastic callus formation                     Unknown

  OI type VI                                                   AD or AR      More fractures than OI IV, vertebral compression fractures, no DI                                                                                   Unknown

  OI type VII                                                  AR            Congenital fractures, blue sclerae, early deformity of lower extremities, coxa vara, osteopenia                                                     Unknown

  Hypophosphatasia, perinatal and infantile form (1/100,000)   AR            Severe undermineralization, bone deformity, fractures                                                                                               TNSALP mutations

  Hypophosphatasia (childhood type)                            AD/AR         Premature loss of teeth, rachitic bone changes, fracture, undermineralization of bones                                                              Urinary phosphoethanolamine, plasma plasma ALP, TNSALPL gene testing

  Juvenile Paget's disease                                     AR            rapidly remodeling bone, osteopenia, fractures, progressive skeletal deformity                                                                      TNFRSF11B mutations[@b18-16778601]

  Bruck syndrome                                               AR            Osteoporosis, joint contractures and fractures and short stature                                                                                    PLOD2 mutations[@b19-16778601]--[@b21-16778601]

  Osteopetrosis with renal tubular acidosis                    AR            Before 2 years of age, fractures, short stature and delayed development. RTA, cerebral calcifications, mental retardation and dental malocclusion   CAII mutations[@b22-16778601]

  Hypophosphatemic osteomalacia "rickets"                      AD, XLD       Before 2, osteomalacia and poor growth. Later hypophosphatemia                                                                                      Low serum phosphorus, elevated alk.phosphatase, low urine calcium\
                                                                                                                                                                                                                                 FGF23, HYP genes[@b23-16778601]

  Non-accidental injury                                        \-            Unexplained fractures in infancy                                                                                                                    
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
